To recapitulate, the prevailing body of genetic and in vivo evidence strongly substantiates the notion that uromodulin primarily acts as a potent inhibitor in the process of kidney stone formation, despite a few studies that may suggest otherwise. The gene discussed is UMOD; the disease is nephrolithiasis.